ABVC BioPharma, Inc. Proceeds from (Repayments of) Related Party Debt
ABVC BioPharma, Inc. (ABVC) reported Proceeds from (Repayments of) Related Party Debt of $153.84 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt · last filed 2026-08-12
- ABVC BioPharma, Inc. proceeds from (repayments of) related party debt for the quarter ending 2026-06-30 was $255.86K.
- ABVC BioPharma, Inc. proceeds from (repayments of) related party debt for the quarter ending 2026-03-31 was -$102.02K, a 320.17% decline year-over-year.
- ABVC BioPharma, Inc. proceeds from (repayments of) related party debt for the quarter ending 2025-09-30 was -$26.98K, a 142.14% decline year-over-year.
- ABVC BioPharma, Inc. proceeds from (repayments of) related party debt for the quarter ending 2025-06-30 was -$90.81K.
- ABVC BioPharma, Inc. proceeds from (repayments of) related party debt for fiscal 2024 was $599.55K.
- ABVC BioPharma, Inc. proceeds from (repayments of) related party debt for fiscal 2023 was -$186.50K.
- ABVC BioPharma, Inc. proceeds from (repayments of) related party debt for fiscal 2020 was $72.70K.
- ABVC BioPharma, Inc. proceeds from (repayments of) related party debt for fiscal 2018 was $211.02K.
| Period end | Proceeds from (Repayments of) Related Party Debt 3 month | Proceeds from (Repayments of) Related Party Debt 6 month | Proceeds from (Repayments of) Related Party Debt 9 month | Proceeds from (Repayments of) Related Party Debt 12 month |
|---|---|---|---|---|
| 2026-06-30 | $255.86K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $153.84K 10-Q · filed 2026-08-12 | ||
| 2026-03-31 | -$102.02K 10-Q · filed 2026-05-18 | |||
| 2025-09-30 | -$26.98K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | -$117.79K derived: sum of 2 quarters · filed 2026-08-12 | -$71.45K 10-Q · filed 2025-11-03 | $312.46K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | -$90.81K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$44.47K 10-Q · filed 2026-08-12 | $339.45K derived: sum of 3 quarters · filed 2026-08-12 | $403.49K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | $46.34K 10-Q · filed 2026-05-18 | $430.26K derived: sum of 2 quarters · filed 2026-05-18 | $494.29K derived: sum of 3 quarters · filed 2026-05-18 | |
| 2024-12-31 | $383.92K derived: 10-K 12 month − 10-Q/A 9 month · filed 2025-04-15 | $447.95K derived: sum of 2 quarters · filed 2026-03-03 | $599.55K 10-K · filed 2025-04-15 | |
| 2024-09-30 | $64.04K derived: 10-Q/A 9 month − 10-Q 6 month · filed 2026-03-03 | $215.63K 10-Q/A · filed 2026-03-03 | ||
| 2024-06-30 | $151.60K 10-Q · filed 2025-08-13 | |||
| 2023-12-31 | -$186.50K 10-K · filed 2025-04-15 | |||
| 2021-03-31 | $4.63K 10-Q · filed 2022-05-16 | $4.90K derived: sum of 2 quarters · filed 2022-05-16 | $5.64K derived: sum of 3 quarters · filed 2022-05-16 | $5.64K derived: sum of 4 quarters · filed 2022-05-16 |
| 2020-12-31 | $271.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $1.02K derived: sum of 2 quarters · filed 2022-03-31 | $1.02K derived: sum of 3 quarters · filed 2022-03-31 | $72.70K 10-K · filed 2022-03-31 |
| 2020-09-30 | $745.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-17 | $745.00 derived: sum of 2 quarters · filed 2020-11-17 | $72.43K 10-Q · filed 2020-11-17 | |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | $71.69K 10-Q · filed 2020-08-14 | ||
| 2020-03-31 | $71.69K 10-Q · filed 2020-06-29 | |||
| 2019-06-30 | $206.72K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | $519.38K 10-Q · filed 2020-08-14 | ||
| 2019-03-31 | $312.66K 10-Q · filed 2020-06-29 | |||
| 2018-12-31 | $211.02K 10-K · filed 2020-05-15 |